Loading company…
Riskpilot
← Back to search
Sign in
Get full access
LEXINOR AS
AS
Active
Org 924020857
Grimelundshaugen 25, 0374 Oslo
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2019
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 2,9M
-54% vs 2024
EBITDA margin
24.3%
-75% vs 2024
Equity ratio
73.7%
Financial strength
Net profit 2025
NOK 419K
-81% vs 2024
EBITDA — year on year
NOK millions
4M
3M
2M
1M
0M
0M
2021
1M
+100%
2022
0M
-100%
2023
3M
+300%
2024
1M
-67%
2025
Key figures
Annual report 2025
Revenue
NOK 2,9M
-54%
EBITDA
NOK 710K
-75%
Net profit
NOK 419K
-81%
Total assets
NOK 3,6M
-24%
Equity
NOK 2,6M
+19%
Employees
0
—
Company information
Legal name
LEXINOR AS
Org number
924020857
Legal form
Aksjeselskap
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
5. desember 2019
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering/kjøp/salg av eiendom, laboratorier og biologiske tjenester, medisinsk og kosmetiske tjenester.
Contact
Address
Grimelundshaugen 25, 0374 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
2M
4M
6M
8M
0M
2021
7M
2022
3M
2023
6M
2024
3M
2025
EBITDA
NOK millions
0M
1M
2M
3M
3M
0M
2021
1M
2022
0M
2023
3M
2024
1M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
6 697
2 998
6 389
2 921
Staff expenses
−0
−0
−0
−737
−833
EBITDA
−7
523
351
2 849
710
Depreciation & amort.
−0
−0
−0
−27
−127
EBIT
−7
523
351
2 822
584
Net financials
0
0
−0
−10
−46
Profit before tax
−7
523
351
2 812
538
Tax
−1
115
78
619
119
Net profit
−7
408
273
2 194
419
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
20
542
2 142
4 705
3 575
Equity
16
424
697
2 215
2 634
Long-term debt
0
0
0
591
480
Short-term debt
4
118
1 445
1 899
460
Total debt
4
118
1 445
2 490
941
Financial ratios
5-year trend
EBITDA margin
24.3%
This company
15.8%
Market median
+54% vs market
2021
2025
Equity ratio
73.7%
This company
38.2%
Market median
+93% vs market
2021
2025
Return on equity
15.9%
This company
18.4%
Market median
+14% vs market
2021
2025
Net profit margin
14.3%
This company
8.1%
Market median
+77% vs market
2021
2025
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
2021
2025
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
KP
Kambiz Persley
Chairman
2019
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of LEXINOR AS also hold positions in
0
other companies.
Person
Role here
Other companies
Kambiz Persley
Chairman
0 companies